Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal

Table 1 Prevalence of chronic atrophic gastritis

Author	Year	Country	Study type	Patients	Age (yr)	CAG (%)
Serology
Sipponen et al[14]	2003	Finland	General population	12 252 (men)	51-65	5.2
Green et al[15]	2005	New Zealand	General population	466	> 65	6.7
Weck et al[16]	2007	Germany	General population	9444	50-74	6
Telaranta-Keerle et al[17]	2010	Finland	General population	4256	18-92	3.5
Histology
Oksanen et al[18]	2000	Finland	Endoscopic cohort	207	19-83	131
Borch et al[19]	2000	Sweden	General Population	501	35-85	9.42
Asaka et al[20]	2001	Japan	General Population	2455	< 20 to > 70	55.53
Redéen et al[21]	2003	Sweden	General Population	488	37-85	9
Storskrubb et al[22]	2008	Sweden	General Population	976	20-80	6.64
Zou et al[23]	2011	China	General Population	1022	18-80	63.83

¹This percentage refers to patients (n = 27) with atrophic body gastritis;

²this percentage refers to patients (n = 47) with atrophic pangastritis and corpus- predominant (gastritis;

³these percentages included chronic atrophic gastritis (CAG) diagnosis irrespective of the atrophy localization in the gastric mucosa (antrum and/or corpus);

⁴this percentage refers to patients (n = 54) with multifocal atrophic gastritis and atrophic corpus- limited gastritis.